G. Vascular function in rats with adenineinduced chronic renal failure. Am J Physiol Regul Integr Comp Physiol 302: R1426 -R1435, 2012. First published April 18, 2012 doi:10.1152/ajpregu.00696.2011The aim of the present study was to characterize the function of resistance arteries, and the aorta, in rats with adenine-induced chronic renal failure (A-CRF). Sprague-Dawley rats were randomized to chow with or without adenine supplementation. After 6 -10 wk, mesenteric arteries and thoracic aortas were analyzed ex vivo by wire myography. Plasma creatinine concentrations were elevated twofold at 2 wk, and eight-fold at the time of death in A-CRF animals. Ambulatory systolic and diastolic blood pressures measured by radiotelemetry were significantly elevated in A-CRF animals from week 3 and onward. At death, A-CRF animals had anemia, hyperphosphatemia, hyperparathyroidism, and elevated plasma levels of asymmetric dimethylarginine and oxidative stress markers. There were no significant differences between groups in the sensitivity, or maximal response, to ACh, sodium nitroprusside (SNP), norepinephrine, or phenylephrine in either mesenteric arteries or aortas. However, in A-CRF animals, the rate of aortic relaxation was significantly reduced following washout of KCl (both in intact and endothelium-denuded aorta) and in response to ACh and SNP. Also the rate of contraction in response to KCl was significantly reduced in A-CRF animals both in mesenteric arteries and aortas. The media of A-CRF aortas was thickened and showed focal areas of fragmented elastic lamellae and disorganized smooth muscle cells. No vascular calcifications could be detected. These results indicate that severe renal failure for a duration of less than 10 wk in this model primarily affects the aorta and mainly slows the rate of relaxation. chronic kidney disease; endothelial function; vascular smooth muscle cells; hypertension; mesenteric arteries; aorta PATIENTS WITH CHRONIC KIDNEY disease (CKD) are at increased risk of cardiovascular (CV) disease and in dialysis patients CV mortality rates are at least 10-to 20-fold higher than in the general population (5). The risk increases already when glomerular filtration rate (GFR) falls below 60 ml·min Ϫ1 ·1.73m
Ϫ2(6) and a majority of CKD patients die from CV disease before developing end-stage renal disease (25). The pathophysiological mechanisms causing the increase in CV risk in CKD patients are in many cases associated with comorbidity, such as primary hypertension, diabetes mellitus, hypercholesterolemia, and established atherosclerotic disease (5, 26). However, the risk of CV death is markedly elevated also in children and young adults with CKD, although these patients often lack comorbidity (20). Also, the causes of CV death are different in CKD patients compared with in the general population with an excess of sudden cardiac deaths (5). Arterial abnormalities in patients with end-stage renal disease are typically characterized by increased stiffness and medial calcifications, which may develop i...